Health ministers condemn Novartis lottery for Zolgensma, the world’s most expensive drug
Novartis has held the first draw to choose four babies who will receive its one-shot treatment for the genetic disease spinal muscular atrophy, Zolgensma (onasemnogene abeparvovec), amid criticism of…
